NEWS DESK

AJX Stock News, News Score & What It Could Mean

AJX is currently showing a neutral headline tone with a mixed / range backdrop. The latest news flow is being framed here as context rather than prediction, so beginners can quickly see whether headlines are helping, hurting, or complicating the chart story. Earnings tone is currently no clear earnings read.

HEADLINE TAKE: The current headline mix looks balanced, so the overall news tone reads neutral right now.
Change stock
Search another ticker to view its latest news page.
Full chart, indicators and drawing tools on TradingView. Move to Platforms when you are ready to act.
NEWS SCORE
50/100
Neutral
Bearish
Neutral
Bullish
Earnings Tone
55
Neutral based on actual EPS/revenue
Confidence
Low
Headline depth
Last Price
$3.02
Trend Context
Mixed / range
Latest briefing

What's happening with AJX

Ad Hoc26 Jun 2026

Great Ajax shows cautious balance sheet move, stock reacts to preferred share issuance - Ad Hoc News

<a href="https://news.google.com/rss/articles/CBMiyAFBVV95cUxQRDIzSm1lbm5PZDFGb0FjZE9kTFpvWW5lYmVCU2hMMXMxUTlHUlZBekxxc045YkpJT1FsNHNlR1JyNGdrOTFqcjZhYUNmSDBJYkJDekp2eXNLNldJRWFBcHItS2JGSVJqNVVBWFNOc083M1RCeGRZLVFYUk5lLXFlNHVTWnJQSWtfSzZySWNTZHg3anVIWkZZQWZGNFd4RXp0YmlKU3VJbFljd3k5VU4weDgydFdtVTRlZ3FsT1NLUzFwZWYtZVkxdA?oc=5" target="_blank">Great Ajax shows cautious balance sheet move, stock reacts to preferred share issuance</a>&nbsp;&nbsp;<font color="#6f6f6f">Ad Hoc News</font>

Article excerpt provided by the FMP news feed. AI is used only for the optional "Why this matters" read.Read full article ↗
smallcaps.com.au24 Jun 2026

ASX Stock Market News | Australian Shares - smallcaps.com.au

<a href="https://news.google.com/rss/articles/CBMilAFBVV95cUxNbi1RYV9takRiUkM0ZjU4b0hSYk03dHVsaVJjRTBZUHFuM1RnVUxHc2xhWFVXdDVRSVNhRm5BeW11WTJJTmJ0ZDlQcDhVUFV2SDVjQmFIWWo4MGFzSHZjY0V3S1dBem5FRlE5aWJqNURIa1JiSXlqZTlRSmdxYTcwdGI3ckdneXE4bWsyS0t4YXY2M2Vw?oc=5" target="_blank">ASX Stock Market News | Australian Shares</a>&nbsp;&nbsp;<font color="#6f6f6f">smallcaps.com.au</font>

Article excerpt provided by the FMP news feed. AI is used only for the optional "Why this matters" read.Read full article ↗
Ad Hoc20 Jun 2026

Great Ajax Stock - analyst consensus in focus - Ad Hoc News

<a href="https://news.google.com/rss/articles/CBMipAFBVV95cUxNZ3VScEFMeUpwX3VnUThvODlJNm81UVByRkhQTHh0NURYUmk0VGVIWGRVWFc5Ym84bS1yZE1EdVh0SkJCMTJKTmVfS0xHTXZLSEN0UE1qZHVLOHIzd1gtay1SaWVGNVp2OGlnak5SN2hJajhYUng5X3BfV2ZhczNyLTFqZWRCMmdtNGdHdlBHUE9RZ0pKQnpUZUMzM0c3RGx0TklPVg?oc=5" target="_blank">Great Ajax Stock - analyst consensus in focus</a>&nbsp;&nbsp;<font color="#6f6f6f">Ad Hoc News</font>

Article excerpt provided by the FMP news feed. AI is used only for the optional "Why this matters" read.Read full article ↗
Older updates drop into a lighter feed
Stock Titan
13 Jun 2026
Lilly trial drug cuts spleen size, symptoms in myelofibrosis - Stock Titan
Read ↗
TradingView
28 Apr 2026
LLY Expands Oncology Pipeline With $2.3B Ajax Therapeutics Acquisition - TradingView
Read ↗
Pharmaceutical Executive
27 Apr 2026
Eli Lilly Enters $ 2.3 Billion Agreement to Acquire Ajax Therapeutics - Pharmaceutical Executive
Read ↗
Business Wire
20 Nov 2024
Great Ajax Establishes Effective Date of Previously Announced Rebrand to Rithm Property Trust - Business Wire
Read ↗
CNBC TV18
3 Jan 2026
Ajax Engineering Ltd. Share Price Today - Ajax Engineering Ltd. Stock Price Live NSE/BSE - CNBC TV18
Read ↗
Earnings news

AJX earnings headlines

This section is separated from the general news feed so investors can quickly connect the latest headlines with the structured earnings report.

1
OncLive13 Jun 2026

AJ1-11095 Shows Spleen Responses and Symptom Improvement in Post–Type I JAK Inhibitor Myelofibrosis - OncLive

<a href="https://news.google.com/rss/articles/CBMixwFBVV95cUxNbFR1aWpHUVU4ZTFOUUIxdHNtZ0VjOU1md20wQW1nQXowVkMxdTVSYjFzRURveEx5RFFWaEY0SGZqRXBIbjBmMjE2b016WHBvTGNPSkdRQ1lZOE9taENyejE4TWNnTTdJV251cHNtb1JHWmhiUUZ5NkpBSU03SVhIdk9yTXMxS1RPWkxIenFmbDV0ZEhSWjFLZzhzQjZ3UHVmT01FajViRF9xaHhBZlNidkd0dmhmQnpSUkxUeFZUZTlqRUxjYU5j?oc=5" target="_blank">AJ1-11095 Shows Spleen Responses and Symptom Improvement in Post–Type I JAK Inhibitor Myelofibrosis</a>&nbsp;&nbsp;<font color="#6f6f6f">OncLive</font>

2
TradingView28 Apr 2026

LLY Expands Oncology Pipeline With $2.3B Ajax Therapeutics Acquisition - TradingView

<a href="https://news.google.com/rss/articles/CBMiwwFBVV95cUxNaFhrRWF3NkhVSnU0bU9mTnBhelhrWG5FRnJmNTFDM29pMlljcm02cGh6Rm5pYlpyWlFVMVhaWlVrQ2V5S2NxRTRvSThwVEJ4eDhfWjlQUVdDejNwVjNPcHRsMkN5WXEtRDVXV2VVcUNjUjJ6b2JMVVRmSV9Gbmk3UjNUNzlEaHhsU19ZUlpLYk9wX0J4X1ljbHBSaXhpRnpxSHdIVjlrTE82a3U2UWdsOWVnX29uS09lUUtOUUZHcDVEZlE?oc=5" target="_blank">LLY Expands Oncology Pipeline With $2.3B Ajax Therapeutics Acquisition</a>&nbsp;&nbsp;<font color="#6f6f6f">TradingView</font>

Beyond the headline

A deeper look for beginners

Generate a short AI read that goes beyond the headlines above, plus a plain-English breakdown of what it could mean going forward.

Continue your AJX research
Use the stock analysis page for a fuller technical read, open TradingView for charting, or head to Platforms when you are ready to place a trade.